Preliminary Evaluation of CASTLE Barrier North American Prototype
NCT01413672 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 30
Last updated 2011-12-12
Summary
The purpose of this study is to determine if an ostomy barrier that promotes a healthy skin environment will result in reduced peristomal skin irritation.
Conditions
- Peristomal Skin Complication
Interventions
- DEVICE
-
Use of CASTLE barrier
Test barrier to be used in place of normal barrier. Otherwise normal routine is followed
Sponsors & Collaborators
-
Hollister Incorporated
lead INDUSTRY
Principal Investigators
-
Richard Murahata, Ph.D. · Hollister Incorporated
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2011-08-31
- Primary Completion
- 2011-12-31
- Completion
- 2011-12-31
Countries
- United States
- Canada
Study Locations
More Related Trials
-
Change in Permeability of the Small Intestine After Treatment With Gluten
NCT02098057 ·Status: COMPLETED ·Phase: NA
-
Gut Microbiota in Chronic GI Diseases
NCT06532110 ·Status: RECRUITING
-
Effect of Chronic Feeding of Inulin And Methylcellulose on Colonic Fermentation
NCT06551961 ·Status: RECRUITING ·Phase: NA
-
IBS Skin Patch Test Food Allergy Study
NCT06288672 ·Status: RECRUITING ·Phase: NA
-
Probiotics and Gut Health
NCT01874301 ·Status: COMPLETED ·Phase: NA
-
Gut Peptides and Intestinal Permeability in Celiac Disease and Irritable Bowel Syndrome
NCT01574209 ·Status: COMPLETED
-
Evaluation of Bowel Sensitivity Threshold in IBS Patients Versus in Healthy Controls Using the Novel Rapid Barostat Bag
NCT03224494 ·Status: UNKNOWN ·Phase: NA
-
"Functional Bowel Disorder. Investigation in General Practice"
NCT01153295 ·Status: COMPLETED ·Phase: NA
-
Detection of Luminal and Mucosa-associated Microbiome in Healthy Controls vs. Local and Systemic Inflammation
NCT03157687 ·Status: COMPLETED
-
Multi-Strain Probiotics Supplementation With Standard Care in Mild to Moderate Ulcerative Colitis
NCT06595719 ·Status: RECRUITING ·Phase: NA
-
The Effect of Dietary Supplementation on Intestinal Barrier Function in IBS-D
NCT06543498 ·Status: COMPLETED ·Phase: NA
-
Effects of the Soluble Mediators of Mastocytes on the Intestinal Epithelial Barrier and of the Enteric Nervous System During the Syndrome of the Irritable Bowel
NCT00742118 ·Status: UNKNOWN ·Phase: NA
-
Validation of New Tests for Gastrointestinal (GI) Permeability
NCT00943345 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Low FODMAP Plus PEG 3350 for the Treatment of Patients with Irritable Bowel Syndrome-Constipation
NCT03687814 ·Status: RECRUITING ·Phase: NA
-
Enabling Microbiomics- Driven Personalized Nutrition
NCT06657001 ·Status: ENROLLING_BY_INVITATION
-
Effect of Probiotic Supplement in Alleviating Functional Gastrointestinal Symptoms
NCT01728610 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Different Dietary Therapies on Intestinal Barrier Integrity in Patients With Irritable Bowel Syndrome
NCT06421922 ·Status: COMPLETED ·Phase: NA
-
Radicle GI Health RDH™: A Study Assessing the Impact of Health and Wellness Products on Gastrointestinal (GI) Health and Related Health Outcomes
NCT07230821 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Effects of DL-endopeptidase Producing Probiotics on Human Intestinal NOD2 Ligands and Related Functions
NCT06716047 ·Status: ACTIVE_NOT_RECRUITING ·Phase: EARLY_PHASE1
-
Irritable Bowel Syndrome and Food Sensitivity
NCT02186743 ·Status: COMPLETED ·Phase: NA
-
Serum-Derived Bovine Immunoglobulin /Protein Isolate (SBI) 5.0 g Bid on Nutritional Status in Subjects With IBS-D
NCT02163213 ·Status: COMPLETED ·Phase: NA
-
Caecal pH as a Biomarker for Irritable Bowel Syndrome
NCT02360384 ·Status: UNKNOWN ·Phase: NA
-
One Year Home Monitoring and Treatment of IBS Patients
NCT03586622 ·Status: UNKNOWN ·Phase: NA
-
Casein Glycomacropeptide in Healthy Subjects
NCT02832700 ·Status: COMPLETED ·Phase: NA
-
Marine Protein Hydrolysate as Dietary Supplement in Irritable Bowel Syndrome
NCT03801057 ·Status: COMPLETED ·Phase: NA